Skip to main content
SpringerLink
Log in

Retinale arterielle Verschlüsse (RAV)

S2e-Leitlinie der Deutschen Ophthalmologischen Gesellschaft (DOG), der Retinologischen Gesellschaft (RG), des Berufsverbands der Augenärzte Deutschlands (BVA). Aktualisierte Version vom 07.10.2022

Retinal arterial occlusions (RAV)

S2e guidelines of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Version: 7 October 2022

  • Leitlinien, Stellungnahmen und Empfehlungen
  • Published:
Die Ophthalmologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Harbour R, Miller J (2001) A new system for grading recommendations in evidence based guidelines. BMJ 323:334–336

    Article  CAS  Google Scholar 

  2. Fraser SG, Adams W (2009) Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 1:CD1989

    Google Scholar 

  3. Hayreh SS (2005) Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24:493–519

    Article  Google Scholar 

  4. Hayreh SS (2011) Acute retinal arterial occlusive disorders. Prog Retin Eye Res 30:359–394

    Article  Google Scholar 

  5. Duker JS, Sivalingam A, Brown GC, Reber R (1991) A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization. Arch Ophthalmol 109:339–342

    Article  CAS  Google Scholar 

  6. Leavitt JA, Larson TA, Hodge DO, Gullerud RE (2011) The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol 152:820–823.e2

    Article  Google Scholar 

  7. Rumelt S, Dorenboim Y, Rehany U (1999) Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 128:733–738 (Erratum appears in Am J Ophthalmol 2000 Dec;130(6):908)

    Article  CAS  Google Scholar 

  8. Rudkin AK, Lee AW, Chen CS (2009) Central retinal artery occlusion: timing and mode of presentation. Eur J Neurol 16:674–677

    Article  CAS  Google Scholar 

  9. Karjalainen K (1971) Occlusion of the central retinal artery and retinal branch arterioles. A clinical, tonographic and fluorescein angiographic study of 175 patients. Acta Ophthalmol 109:1–96

    CAS  Google Scholar 

  10. Brown GC, Magargal LE (1982) Central retinal artery obstruction and visual acuity. Ophthalmology 89:14–19

    Article  CAS  Google Scholar 

  11. Hayreh SS (2014) Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res 41:1–25

    Article  Google Scholar 

  12. Uhr JH, Mishra K, Wei C, Wu AY (2016) Awareness and knowledge of emergent ophthalmic disease among patients in an internal medicine clinic. JAMA Ophthalmol 134:424–431

    Article  Google Scholar 

  13. Schmidt D, Schumacher M, Feltgen N (2009) Circadian incidence of non-inflammatory retinal artery occlusions. Graefes Arch Clin Exp Ophthalmol 247:491–494

    Article  Google Scholar 

  14. Hayreh SS, Podhajsky PA, Zimmerman MB (2009) Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology 116:1928–1936

    Article  Google Scholar 

  15. Hayreh SS, Zimmerman MB (2007) Fundus changes in central retinal artery occlusion. Retina 27:276–289

    Article  Google Scholar 

  16. Wong TY, Klein R (2002) Retinal arteriolar emboli: epidemiology and risk of stroke. Curr Opin Ophthalmol 13:142–146

    Article  Google Scholar 

  17. Naumann G (1997) Pathologie des Auges. In: Naumann G (Hrsg) Embryologie, Anatomie und Untersuchungstechnik, 2. Aufl. Bd. 1. Springer, Berlin

    Google Scholar 

  18. Hayreh SS, Zimmerman MB (2014) Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses. Retina 34:115–122

    Article  Google Scholar 

  19. Petzold A, Islam N, Hu H‑H, Plant GT (2013) Embolic and nonembolic transient monocular visual field loss: a clinicopathologic review. Surv Ophthalmol 58:42–62

    Article  Google Scholar 

  20. Terelak-Borys B, Skonieczna K, Grabska-Liberek I (2012) Ocular ischemic syndrome—a systematic review. Med Sci Monit 18:RA138–144

    Article  Google Scholar 

  21. BVA (1998) Augenärztliche Basisdiagnostik bei Patienten ab dem 7. Lebensjahr

    Google Scholar 

  22. Ness T, Bley TA, Schmidt WA, Lamprecht P (2013) The diagnosis and treatment of giant cell arteriitis. Dtsch Arztebl Int 110:376–385 (quiz 386)

    Google Scholar 

  23. Buttgereit F, Brabant T, Dinges H et al (2017) S3-Leitlinie zur Behandlung der Polymyalgia rheumatica (AWMF-Leitlinien-Register)

    Google Scholar 

  24. Kermani TA, Schmidt J, Crowson CS et al (2012) Utility of erythrocyte sedimentation rate and C‑reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41:866–871

    Article  CAS  Google Scholar 

  25. Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S et al (2005) Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine 84:277–290

    Article  Google Scholar 

  26. Brown GC, Magargal LE (1988) The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol 11:239–251

    Article  CAS  Google Scholar 

  27. Duker JS, Cohen MS, Brown GC, Sergott RC, McNamara JA (1990) Combined branch retinal artery and central retinal vein obstruction. Retina 10:105–112

    Article  CAS  Google Scholar 

  28. Chen S‑N, Hwang J‑F, Chen Y‑T (2011) Macular thickness measurements in central retinal artery occlusion by optical coherence tomography. Retina 31:730–737

    Article  Google Scholar 

  29. Ritter M, Sacu S, Deák GG et al (2012) In vivo identification of alteration of inner neurosensory layers in branch retinal artery occlusion. Br J Ophthalmol 96:201–207

    Article  Google Scholar 

  30. Schmidt D, Kube T, Feltgen N (2006) Central retinal artery occlusion: findings in optical coherence tomography and functional correlations. Eur J Med Res 11(6):250–252

    Google Scholar 

  31. Wenzel DA, Kromer R, Poli S et al (2021) Optical coherence tomography-based determination of ischaemia onset—the temporal dynamics of retinal thickness increase in acute central retinal artery occlusion. Acta Ophthalmol 99:e247–e252. https://doi.org/10.1111/aos.14563

    Article  Google Scholar 

  32. Casagrande M, Kromer R, Wenzel DA et al (2021) Determination of ischemia onset based on automatically generated spectralis SD-OCT values in acute central retinal artery occlusion. J Ophthalmol 2021:5527292

    Article  Google Scholar 

  33. Chu YK, Hong YT, Byeon SH, Kwon OW (2013) In vivo detection of acute ischemic damages in retinal arterial occlusion with optical coherence tomography: a „prominent middle limiting membrane sign“. Retina 33:2110–2117

    Article  Google Scholar 

  34. Dotan G, Goldenberg D, Kesler A, Naftaliev E, Loewenstein A, Goldstein M (2014) The use of spectral-domain optical coherence tomography for differentiating long-standing central retinal artery occlusion and nonarteritic anterior ischemic optic neuropathy. Ophthalmic Surg Lasers Imaging Retina 45:38–44

    Article  Google Scholar 

  35. Brown GC, Magargal LE, Federman JL (1980) Ischaemia and neovascularization. Trans Ophthalmol Soc U K 100:377–380

    CAS  Google Scholar 

  36. Brown GC, Magargal LE, Simeone FA, Goldberg RE, Federman JL, Benson WE (1982) Arterial obstruction and ocular neovascularization. Ophthalmology 89:139–146

    Article  CAS  Google Scholar 

  37. Duker JS, Brown GC (1988) Iris neovascularization associated with obstruction of the central retinal artery. Ophthalmology 95:1244–1250

    Article  CAS  Google Scholar 

  38. Hayreh SS, Podhajsky PA, Zimmerman MB (2009) Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology 116:1188–1194.e1‑4

    Article  Google Scholar 

  39. Hayreh SS, Zimmerman MB (2005) Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140:376–391

    Article  Google Scholar 

  40. Schirmer JH, Aries PM, Balzer K et al (2020) S2k guidelines: management of large-vessel vasculitis. Z Rheumatol 79:67–95

    Article  CAS  Google Scholar 

  41. Rim TH, Han J, Choi YS et al (2016) Retinal artery occlusion and the risk of stroke development: twelve-year nationwide cohort study. Stroke 47:376–382

    Article  Google Scholar 

  42. Chang Y‑S, Jan R‑L, Weng S‑F et al (2012) Retinal artery occlusion and the 3‑year risk of stroke in Taiwan: a nationwide population-based study. Am J Ophthalmol 154:645–652.e1

    Article  Google Scholar 

  43. Amarenco P, Lavallée PC, Labreuche J et al (2016) One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med 374:1533–1542

    Article  CAS  Google Scholar 

  44. Park SJ, Choi N‑K, Yang BR et al (2015) Risk and risk periods for stroke and acute myocardial infarction in patients with central retinal artery occlusion. Ophthalmology 122:2336–2343.e2

    Article  Google Scholar 

  45. Christiansen CB, Torp-Pedersen C, Olesen JB et al (2018) Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study. BMC Cardiovasc Disord 18:91

    Article  Google Scholar 

  46. Lavin P, Patrylo M, Hollar M, Espaillat KB, Kirshner H, Schrag M (2018) Stroke risk and risk factors in patients with central retinal artery occlusion. Am J Ophthalmol 196:96–100

    Article  Google Scholar 

  47. Scoles D, McGeehan B, VanderBeek BL (2022) The association of stroke with central and branch retinal arterial occlusion. Eye (Lond) 36(4):835–843. https://doi.org/10.1038/s41433-021-01546-6

    Article  Google Scholar 

  48. Fallico M, Lotery AJ, Longo A et al (2020) Risk of acute stroke in patients with retinal artery occlusion: a systematic review and meta-analysis. Eye (Lond) 34:683–689

    Article  Google Scholar 

  49. Zhou Y, Zhu W, Wang C (2016) Relationship between retinal vascular occlusions and incident cerebrovascular diseases: a systematic review and meta-analysis. Medicine 95:e4075

    Article  Google Scholar 

  50. Mir TA, Arham AZ, Fang W et al (2019) Acute vascular ischemic events in patients with central retinal artery occlusion in the United States: a nationwide study 2003–2014. Am J Ophthalmol 200:179–186

    Article  Google Scholar 

  51. Biousse V, Nahab F, Newman NJ (2018) Management of acute retinal ischemia: follow the guidelines! Ophthalmology 125:1597–1607

    Article  Google Scholar 

  52. Hoyer C, Kahlert C, Güney R, Schlichtenbrede F, Platten M, Szabo K (2021) Central retinal artery occlusion as a neuro-ophthalmological emergency: the need for raising public awareness. Eur J Neurol 28(6):2111–2114. https://doi.org/10.1111/ene.14735

    Article  Google Scholar 

  53. Mac Grory B, Schrag M, Biousse V et al (2021) Management of central retinal artery occlusion: a scientific statement from the American heart association. Stroke 52:e282–94

    Article  Google Scholar 

  54. Flaxel CJ, Adelman RA, Bailey ST et al (2020) Retinal and ophthalmic artery occlusions preferred practice pattern. Ophthalmology 127:P259–87

    Article  Google Scholar 

  55. Callizo J, Feltgen N, Pantenburg S et al (2015) Cardiovascular risk factors in central retinal artery occlusion: results of a prospective and standardized medical examination. Ophthalmology 122:1881–1888

    Article  Google Scholar 

  56. Leisser C, Kaufmann TA, Feltgen N, Schumacher M, Schmoor C, Meckel S (2015) Distribution of internal carotid artery plaque locations among patients with central retinal artery occlusion in the eagle study population. Graefes Arch Clin Exp Ophthalmol 253:1227–1230

    Article  CAS  Google Scholar 

  57. Rudkin AK, Lee AW, Chen CS (2010) Vascular risk factors for central retinal artery occlusion. Eye (Lond) 24:678–681

    Article  CAS  Google Scholar 

  58. Hayreh SS (1971) Pathogenesis of occlusion of the central retinal vessels. Am J Ophthalmol 72:998–1011

    Article  CAS  Google Scholar 

  59. Schmidt D, Hetzel A, Geibel-Zehender A, Schulte-Monting J (2007) Systemic diseases in non-inflammatory branch and central retinal artery occlusion—an overview of 416 patients. Eur J Med Res 12:595–603

    Google Scholar 

  60. Pielen A, Pantenburg S, Schmoor C et al (2015) Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment. Neuroradiology 57:1055–1062

    Article  Google Scholar 

  61. Kermani TA, Warrington KJ (2012) Recent advances in diagnostic strategies for giant cell arteritis. Curr Neurol Neurosci Rep 12:138–144

    Article  Google Scholar 

  62. Hayreh SS, Kolder HE, Weingeist TA (1980) Central retinal artery occlusion and retinal tolerance time. Ophthalmology 87:75–78

    Article  CAS  Google Scholar 

  63. Atebara NH, Brown GC, Cater J (1995) Efficacy of anterior chamber paracentesis and carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology 102:2029–2034 (discussion 2034–2035)

    Article  CAS  Google Scholar 

  64. Augsburger JJ, Magargal LE (1980) Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol 64:913–917

    Article  CAS  Google Scholar 

  65. Brown GC (1991) Retinal vascular diseases. J Ophthalmic Nurs Technol 10:71–75

    CAS  Google Scholar 

  66. Mason JO, Shah AA, Vail RS, Nixon PA, Ready EL, Kimble JA (2008) Branch retinal artery occlusion: visual prognosis. Am J Ophthalmol 146:455–457

    Article  Google Scholar 

  67. Fraser S, Siriwardena D (2002) Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 1:CD1989

    Google Scholar 

  68. Varma DD, Cugati S, Lee AW, Chen CS (2013) A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond) 27:688–697

    Article  CAS  Google Scholar 

  69. Pielen A, Junker B, Hansen L, Agostini H, Feltgen N (2010) Diagnostik und Therapie beim nicht arteriitischen Zentralarterienverschluss. Klin Monbl Augenheilkd 227:712–720

    Article  CAS  Google Scholar 

  70. Feltgen N, Schmidt D, Hansen L (2003) Arterielle retinale Verschlusse. Ophthalmologe 100:651–665 (quiz 666–7)

    Article  CAS  Google Scholar 

  71. Hattenbach L‑O, Kuhli-Hattenbach C, Scharrer I, Baatz H (2008) Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 146:700–706

    Article  CAS  Google Scholar 

  72. Schrag M, Youn T, Schindler J, Kirshner H, Greer D (2015) Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol 72:1148–1154

    Article  Google Scholar 

  73. Schultheiss M, Härtig F, Spitzer MS et al (2018) Intravenous thrombolysis in acute central retinal artery occlusion—a prospective interventional case series. PLoS ONE 13:e198114

    Article  Google Scholar 

  74. Schultheiss M, Spitzer MS, Hattenbach L‑O, Poli S (2021) Update on intravenous lysis treatment : the REVISION trial. Ophthalmologe 118(11):1107–1112. https://doi.org/10.1007/s00347-021-01467-5

    Article  Google Scholar 

  75. Chen CS, Lee AW, Campbell B et al (2011) Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke 42:2229–2234

    Article  CAS  Google Scholar 

  76. Schumacher M, Schmidt D, Jurklies B et al (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117:1367–1375.e1

    Article  Google Scholar 

  77. Hayreh SS, Zimmerman MB, Kimura A, Sanon A (2004) Central retinal artery occlusion. Retinal survival time. Exp Eye Res 78:723–736

    Article  CAS  Google Scholar 

  78. Sandercock P, Gubitz G, Foley P, Counsell C (2003) Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2:CD29

    Google Scholar 

  79. Rothwell PM, Algra A, Chen Z, Diener H‑C, Norrving B, Mehta Z (2016) Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet 388:365–375

    Article  CAS  Google Scholar 

  80. Ringleb P, Hametner C, Köhrmann M et al (2021) Akuttherapie des ischämischen Schlaganfalls (Se2-Leitlinie. AMWF RegNr. 030-046)

    Google Scholar 

  81. Fieß A, Cal O, Kehrein S, Halstenberg S, Frisch I, Steinhorst UH (2014) Anterior chamber paracentesis after central retinal artery occlusion: a tenable therapy? BMC Ophthalmol 14:28

    Article  Google Scholar 

  82. Barbón-García JJ, Alvarez-Suárez ML (2007) Paracentesis and ocular massage as treatment ofcentral retinal artery occlusion. Arch Soc Esp Oftalmol 82:657–659

    Article  Google Scholar 

  83. Mueller A, Neubauer A, Schaller U, Kampik A, European Assessment Group for Lysis in the Eye (2003) Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 121:1377–1381

    Article  Google Scholar 

  84. Duxbury O, Bhogal P, Cloud G, Madigan J (2014) Successful treatment of central retinal artery thromboembolism with ocular massage and intravenous acetazolamide. BMJ Case Rep 2014:bcr2014207943. https://doi.org/10.1136/bcr-2014-207943

    Article  Google Scholar 

  85. Schmidt D (2000) Ocular massage in a case of central retinal artery occlusion the successful treatment of a hitherto undescribed type of embolism. Eur J Med Res 5:157–164

    CAS  Google Scholar 

  86. Hollenhorst RW (1961) Significance of bright plaques in the retinal arterioles. Trans Am Ophthalmol Soc 59:252–273

    CAS  Google Scholar 

  87. Hayreh SS (2007) Comment re: multicenter study of the European assessment group for lysis in the eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. Graefes Arch Clin Exp Ophthalmol 245:464–466

    Article  Google Scholar 

  88. Noble J, Weizblit N, Baerlocher MO, Eng KT (2008) Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol 92:588–593

    Article  CAS  Google Scholar 

  89. Bertram B, Wolf S, Fisches H, Schulte K, Hoberg A, Reim M (1991) Thrombolytic treatment of retinal arterial occlusions with plasminogen activator. Klin Monatsbl Augenheilkd 198:295–300

    Article  CAS  Google Scholar 

  90. Feltgen N, Schmidt D, Schumacher M (2007) Response to comment: multicenter study of the European assessment group for lysis in the eye (EAGLE-group) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE study report no. 1. Graefes Arch Clin Exp Ophthalmol 245:467–470

    Article  Google Scholar 

  91. Feltgen N, Neubauer A, Jurklies B et al (2006) Multicenter study of the European assessment group for lysis in the eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE study report no. 1: EAGLE study report no. 1. Graefes Arch Clin Exp Ophthalmol 244:950–956

    Article  CAS  Google Scholar 

  92. Beatty S, Au Eong KG (2000) Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 84:914–916

    Article  CAS  Google Scholar 

  93. Hazin R, Dixon JA, Bhatti MT (2009) Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy? Curr Opin Ophthalmol 20:210–218

    Article  Google Scholar 

  94. Vallee JN, Aymard A, Paques M, Santiago PY, Gaudric A, Merland JJ (2001) Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion. J Radiol 82:137–144

    CAS  Google Scholar 

  95. von Mach M‑A, Güz A, Wiechelt J, Pfeiffer N, Weilemann LS (2005) Systemic fibrinolytic therapy using urokinase in central retinal artery occlusion. A case study. Dtsch Med Wochenschr 130:1002–1006

    Google Scholar 

  96. Deutsche Schlaganfall Gesellschaft (2015) Sekundärprophylaxe ischämischer Schlaganfall und transitorische ischämische Attacke (AWMF-Register Nr. 030-133)

    Google Scholar 

  97. Dumitrascu OM, Newman NJ, Biousse V (2020) Thrombolysis for central retinal artery occlusion in 2020: time is vision! J Neuroophthalmol 40:333–345

    Article  Google Scholar 

  98. Huang L, Wang Y, Zhang R (2022) Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis. J Neurol 269(4):1825–1833. https://doi.org/10.1007/s00415-021-10838-6

    Article  Google Scholar 

  99. Ochakovski GA, Wenzel DA, Spitzer MS et al (2020) Retinal oedema in central retinal artery occlusion develops as a function of time. Acta Ophthalmol. https://doi.org/10.1111/aos.14375

    Article  Google Scholar 

  100. Schmidt DP, Schulte-Mönting J, Schumacher M (2002) Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol 23:1301–1307

    Google Scholar 

  101. Page PS, Cambon AC, James RF (2016) Visual improvement after intra-arterial thrombolysis for central retinal artery occlusion does not correlate with time to treatment. Interv Neurol 5:131–139

    Article  Google Scholar 

  102. Kiesewetter H, Blume J, Jung F, Spitzer S, Wenzel E (1990) Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb. J Intern Med 227:107–114

    Article  CAS  Google Scholar 

  103. Roth S (1992) The effects of isovolumic hemodilution on ocular blood flow. Exp Eye Res 55:59–63

    Article  CAS  Google Scholar 

  104. Neely KA, Ernest JT, Goldstick TK, Linsenmeier RA, Moss J (1996) Isovolemic hemodilution increases retinal tissue oxygen tension. Graefes Arch Clin Exp Ophthalmol 234:688–694

    Article  CAS  Google Scholar 

  105. Rüfer F, Schröder A, Winter R, Erb C (2003) Analysis of risk factors and comparison of heparin and hemodilution therapies for retinal artery occlusion. Ophthalmologe 100:819–824

    Article  Google Scholar 

  106. Wiederholt M, Leonhardt H, Schmid-Schönbein H, Hager H (1980) Treatment of central retinal venous and arterial occlusion by isovolemic hemodilution (author’s transl). Klin Monatsbl Augenheilkd 177:157–164

    Article  CAS  Google Scholar 

  107. Wolf S, Hoberg A, Bertram B, Jung F, Kiesewetter H, Reim M (1989) Video fluorescein angiography follow-up of patients with retinal artery occlusion. Klin Monatsbl Augenheilkd 195:154–160

    Article  CAS  Google Scholar 

  108. Arend O, Hoberg A, Bertram B, Reim M, Wolf S (1991) Hemodilution in acute arterial circulatory disorders of the retina. Acta Med Austriaca 18:66–68

    Google Scholar 

  109. Hartog CS, Welte T, Schlattmann P, Reinhart K (2013) Fluid replacement with hydroxyethyl starch in critical care—a reassessment. Dtsch Arztebl Int 110:443–450

    Google Scholar 

  110. (2018) Hydroxyethylstärke(HES)-haltige Arzneimittel zur Infusion: Neue Maßnahmen zur Verstärkung der bestehenden Beschränkungen aufgrund eines erhöhten Risikos von Nierenfunktionsstörungen und tödlichen Verläufen bei kritisch kranken oder septischen Patienten

  111. Diener H‑C, Aisenberg J, Ansell J et al (2017) Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. Eur Heart J 38(12):852–859. https://doi.org/10.1093/eurheartj/ehv643

    Article  CAS  Google Scholar 

  112. Diener H‑C, Aisenberg J, Ansell J et al (2017) Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. Eur Heart J 38(12):860–868. https://doi.org/10.1093/eurheartj/ehw069

    Article  CAS  Google Scholar 

  113. Diener H‑C, Kleinschnitz C (2016) Non-vitamin K oral anticoagulants in stroke patients: practical issues. J Stroke 18:138–145

    Article  Google Scholar 

  114. Vestergaard N, Torp-Pedersen C, Vorum H, Aasbjerg K (2021) Risk of stroke, myocardial infarction, and death among patients with retinal artery occlusion and the effect of antithrombotic treatment. Transl Vis Sci Technol 10:2

    Article  Google Scholar 

  115. Desola J, Amselem L (2016) Central retinal artery occlusion rational of the application of hyperbaric oxygenation. European Consensus Conference on Hyperbaric Medicine, Lille, France

    Google Scholar 

  116. Karaman S, Ozkan B, Yazir Y et al (2016) Comparison of hyperbaric oxygen versus iloprost treatment in an experimental rat central retinal artery occlusion model. Graefes Arch Clin Exp Ophthalmol 254:2209–2215

    Article  CAS  Google Scholar 

  117. Hadanny A, Maliar A, Fishlev G et al (2017) Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen. Clin Ophthalmol 11:115–125

    Article  CAS  Google Scholar 

  118. Soares A, Gomes NL, Mendonça L, Ferreira C (2017) The efficacy of hyperbaric oxygen therapy in the treatment of central retinal artery occlusion. BMJ Case Rep 2017:bcr2017220113

    Article  Google Scholar 

  119. Schmidt I, Walter P, Siekmann U et al (2020) Development of visual acuity under hyperbaric oxygen treatment (HBO) in non arteritic retinal branch artery occlusion. Graefes Arch Clin Exp Ophthalmol 258(2):303–310. https://doi.org/10.1007/s00417-019-04568-9

    Article  CAS  Google Scholar 

  120. Lopes AS, Basto R, Henriques S et al (2019) Hyperbaric oxygen therapy in retinal arterial occlusion: epidemiology, clinical approach, and visual outcomes. Case Rep Ophthalmol Med 2019:9765938

    Google Scholar 

  121. Celebi ARC (2021) Hyperbaric oxygen therapy for central retinal artery occlusion: patient selection and perspectives. Clin Ophthalmol 15:3443–3457

    Article  Google Scholar 

  122. Rozenberg A, Hadad A, Peled A et al (2022) Hyperbaric oxygen treatment for non-arteritic central retinal artery occlusion retrospective comparative analysis from two tertiary medical centres. Eye (Lond) 36(6):1261–1265. https://doi.org/10.1038/s41433-021-01617-8

    Article  CAS  Google Scholar 

  123. Cope A, Eggert JV, O’Brien E (2011) Retinal artery occlusion: visual outcome after treatment with hyperbaric oxygen. Diving Hyperb Med 41:135–138

    Google Scholar 

  124. Menzel-Severing J, Siekmann U, Weinberger A, Roessler G, Walter P, Mazinani B (2012) Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction. Am J Ophthalmol 153:454–459.e2

    Article  CAS  Google Scholar 

  125. Aisenbrey S, Krott R, Heller R, Krauss D, Rössler G, Heimann K (2000) Hyperbaric oxygen therapy in retinal artery occlusion. Ophthalmologe 97:461–467

    Article  CAS  Google Scholar 

  126. Weiss JN (2009) Hyperbaric oxygen treatment of nonacute central retinal artery occlusion. Undersea Hyperb Med 36:401–405

    CAS  Google Scholar 

  127. Gaydar V, Ezrachi D, Dratviman-Storobinsky O, Hofstetter S, Avraham-Lubin BCR, Goldenberg-Cohen N (2011) Reduction of apoptosis in ischemic retinas of two mouse models using hyperbaric oxygen treatment. Invest Ophthalmol Vis Sci 52:7514–7522

    Article  CAS  Google Scholar 

  128. Johnson DR, Cooper JS (2019) Retinal artery and vein occlusions successfully treated with hyperbaric oxygen. Clin Pract Cases Emerg Med 3:338–340

    Article  Google Scholar 

  129. Christiansen CB, Lip GYH, Lamberts M, Gislason G, Torp-Pedersen C, Olesen JB (2013) Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation. J Thromb Haemost 11:1485–1492

    Article  CAS  Google Scholar 

  130. Huang X, Yang Y, Duan Y, Kuang Y‑Q, Lin D (2017) Homocysteine in retinal artery occlusive disease: a meta-analysis of cohort studies. Sci Rep 7:15708

    Article  Google Scholar 

  131. Romiti GF, Corica B, Borgi M et al (2020) Inherited and acquired thrombophilia in adults with retinal vascular occlusion: a systematic review and meta-analysis. J Thromb Haemost 18:3249–3266

    Article  CAS  Google Scholar 

  132. Hellmich B, Agueda A, Monti S et al (2020) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79:19–30

    Article  Google Scholar 

Download references

Redaktionskomitee

Prof. Dr. med. Nicolas Feltgen (federführend) DOG, RG, BVA; Prof. Dr. med. Bernd Bertram (Koordinator) DOG, RG, BVA; Dr. med. Daniela Claessens (Leitlinienreport) DOG, RG, BVA; Prof. Dr. med. Alexander Schuster (systematische Literaturrecherche) DOG, BVA; Prof. Dr. med. Hansjürgen Agostini DOG, RG; Prof. Dr. med. Lars-Olof Hattenbach DOG, RG, BVA; Prof. Dr. med. Horst Helbig DOG, RG, BVA; Prof. Dr. med. Hans Hoerauf DOG, RG, BVA; Prof. Dr. med. Frank Holz DOG, RG, BVA; Angelika Ostrowski DBSV; Prof. Dr. med. Martin Spitzer DOG, RG, BVA; Prof. Dr. med. Focke Ziemssen DOG, RG, BVA

Author information

Authors and Affiliations

    Consortia

    Deutsche Ophthalmologische Gesellschaft (DOG)

    • Nicolas Feltgen
    • , Bernd Bertram
    • , Daniela Claessens
    • , Alexander Schuster
    • , Hansjürgen Agostini
    • , Lars-Olof Hattenbach
    • , Horst Helbig
    • , Hans Hoerauf
    • , Frank Holz
    • , Angelika Ostrowski
    • , Martin Spitzer
    •  & Focke Ziemssen

    Retinologische Gesellschaft e. V. (RG)

    Berufsverband der Augenärzte Deutschlands e. V. (BVA)

    Ethics declarations

    Interessenkonflikt

    Siehe Tab. 3 im Anhang

    Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

    The supplement containing this article is not sponsored by industry.

    Additional information

    AWMF-Registernummer: 045-013, Leitlinien-Klasse: S2e

    Versionsnummer: 2.0

    Erstveröffentlichung: 11/2016

    Letzte inhaltliche Bearbeitung: 03/2022

    Nächste Überprüfung geplant: 03/2027

    Das Redaktionskomitee dieser Stellungnahme wird am Beitragsende gelistet.

    figure qr

    QR-Code scannen & Beitrag online lesen

    Anhang

    Anhang

    Tabelle zur Erklärung von Interessen und Umgang mit Interessenkonflikten

    Im Folgenden sind die Interessenerklärungen als tabellarische Zusammenfassung dargestellt sowie die Ergebnisse der Interessenkonfliktbewertung und Maßnahmen, die nach Diskussion der Sachverhalte von der LL-Gruppe beschlossen und im Rahmen der Konsensuskonferenz umgesetzt wurden (Tab. 3).

    Tab. 3 Erklärung von Interessen und Umgang mit Interessenkonflikten – Leitlinienkoordination: Bertram, Bernd; Leitlinie: Retinale arterielle Verschlüsse; Registernummer: 045-13
    Full size table

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Deutsche Ophthalmologische Gesellschaft (DOG)., Retinologische Gesellschaft e. V. (RG). & Berufsverband der Augenärzte Deutschlands e. V. (BVA). Retinale arterielle Verschlüsse (RAV). Ophthalmologie 120 (Suppl 1), 15–29 (2023). https://doi.org/10.1007/s00347-022-01780-7

    Download citation

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00347-022-01780-7

    Schlüsselwörter

    Keywords

    Search

    Navigation